Anti-HCV antibody positivity of various sections of Pakistani patients

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 11, 2009, Pages 737-741

  Umar, Muhammad ^a   Khaar, Hamama Tul Bushra ^a   Khurram, Muhammad ^a   Hasan, Zubair ^b  

^a RAWALPINDI MEDICAL COLLEGE   (Pakistan)

^b Pakistan Atomic Energy Commision ^*  (Pakistan)

Author keywords

Anti HCV antibody; Blood donor; Community; Hepatitis C virus; Review liver disease

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CHI SQUARE TEST; CHILD; COMMUNITY; HEPATITIS C; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MASS SCREENING; PAKISTAN; POPULATION RESEARCH;

HEPATITIS C; HUMANS; PAKISTAN; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 73349127798     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41.
2. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29(Suppl 1):74-81.
3. Marcellin P. Hepatitis B and C in 2009. Liver Int 2009; 29 (Suppl 1):1-8.
4. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3:41-6. Epub 2006 Apr 1.
5. Raja NS, Janjua KA. Epedemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008; 41:4-8.
6. Shah NH, Shabbeir G. A review of published literature on hepatitis B and C virus prevalence in Pakistan. J Coll Physicians Surg Pak 2002; 12:368-71.
7. Umar M, Hamama-Tul-Bushra, editors. Hepatitis C in Pakistan. Islamabad: SAF Publishers; 2006.
8. Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nandakumar S, Murugavel KG, et al. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int J Infect Dis 2008; 12:513-8. Epub 2008 May 5.
9. Devi KS, Singh NB, Mara J, Singh TB, Singh YM. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur: a preliminary report. Indian J Med Microbiol 2004; 22:136-7.
10. Alavian SM, Fallahian F. Comparison of seroepedemiology and transmission modes of viral hepatitis C in Iran and Pakistan. Hepatitis Monthly 2008; 8:51-9.
11. Alavian SM, Abidi P, Zali MR. Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iranian Med 2005; 8:84-90.
12. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, et al. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int 2002; 1:194-201.
13. Mukhopadhya A. Hepatitis C in India. J Biosci 2008; 33:465-73.
14. Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14:534-6.
15. Hyder SN, Hussain W, Aslam M, Maqbool S. Seroprevalence of anti-HCV in asymptomatic children. Pak J Pathol 2001; 25:89-93.
16. Sood A, Midha V, Sood N, Awasthi G. Prevalence of anti-HCV antibodies among family contacts of hepatitis C virus: infected patients. Indian J Gastroenterol 2002; 21:185-7.
17. Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with B-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol 2007; 6:41.
18. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and hemodialysis patients in North Iran-Rasht. J Viral Hepat 2002; 9:390-2.
19. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37:802-9.
20. Zhang M, Sun XD, Mark SD, Chen W, Wong L, Dawsey SM, et al. Hepatitis C virus infection, Linxian, China. Emerg Infect Dis 2005; 11:17-21.
21. Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A. Prevalence and risk factors for hepatitis C virus among pregnant women. Indian J Med Res 2007; 126:211-5.
22. Todd CS, Abed AMS, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behaviour in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 2007; 13:1327-31.
23. Naini MM, Derakhshan F, Hourfar H, Derakhshan R, Rajab FM. Analysis of the related factors in hepatitis C virus infection among hemophilic patients in Isfahan, Iran. Hepatitis Monthly 2007; 7:59-62.
24. Hyder AA, Morrow RH. Applying burden of disease methods in developing countries: a case study from Pakistan. Am J Public Health 2000; 90:1235-40. Comment in: Am J Public Health 2001; 91:652-3.
25. Government of Pakistan; Statistics Division. Household integrated economic survey (HIES) 2005-06. Islamabad: Federal bureau of Statistics; 2007.